STERIS plc Accrued Liabilities for Commissions, Expense and Taxes
STERIS plc (STE) had Accrued Liabilities for Commissions, Expense and Taxes of $19.70 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes
us-gaap:AccruedLiabilitiesForCommissionsExpenseAndTaxes · last filed 2026-08-07
- 2026-06-30: Accrued Liabilities for Commissions, Expense and Taxes $19.70M.
- 2026-03-31: Accrued Liabilities for Commissions, Expense and Taxes $39.60M.
- 2025-12-31: Accrued Liabilities for Commissions, Expense and Taxes $32.30M.
- 2025-09-30: Accrued Liabilities for Commissions, Expense and Taxes $24.50M.
| Period end | Accrued Liabilities for Commissions, Expense and Taxes | Accrued Liabilities for Commissions, Expense and Taxes as first filed |
|---|---|---|
| 2026-06-30 | $19.70M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $39.60M 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $32.30M 10-Q · filed 2026-02-06 | |
| 2025-09-30 | $24.50M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $19.30M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $37.40M 10-K · filed 2026-05-29 | $37.44M 10-K · filed 2025-05-29 |
| 2024-12-31 | $25.71M 10-Q · filed 2025-02-07 | |
| 2024-09-30 | $21.26M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $15.67M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $35.98M 10-K · filed 2025-05-29 | |
| 2023-12-31 | $31.57M 10-Q · filed 2024-02-08 | |
| 2023-09-30 | $24.73M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $17.42M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $26.92M 10-K · filed 2024-05-29 | $29.26M 10-K · filed 2023-05-26 |
| 2022-12-31 | $21.52M 10-Q · filed 2023-02-08 | |
| 2022-09-30 | $18.24M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $13.60M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $30.17M 10-K · filed 2023-05-26 | |
| 2021-12-31 | $18.96M 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $16.18M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $15.95M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $24.02M 10-K · filed 2022-05-31 | |
| 2020-12-31 | $14.59M 10-Q · filed 2021-02-09 | |
| 2020-09-30 | $12.01M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $8.88M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $19.30M 10-K · filed 2021-05-28 | |
| 2019-12-31 | $15.81M 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $12.39M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $10.30M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $17.85M 8-K · filed 2021-02-09 | |
| 2018-03-31 | $17.17M 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |